SCINEURO
SciNeuro is a biotechnology company focused on developing innovative medicines for patients with central nervous system diseases.
SCINEURO
Industry:
Biopharma Biotechnology Neuroscience
Founded:
2020-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.scineuro.com
Total Employee:
11+
Status:
Active
Total Funding:
100 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins Euro
Similar Organizations
Sagimet Biosciences
Sagimet Biosciences is a biotechnology company that focuses on developing novel therapeutics to treat important diseases.
Antengene Corporation
Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Positive Sequence Biology
Positive Sequence Biology is a biotech company with new gene system-based editing, focused on biotech innovation & breakthrough therapies.
Current Advisors List
Current Employees Featured
Founder
Investors List
Sequoia Capital China
Sequoia Capital China investment in Series A - SciNeuro
ARCH Venture Partners
ARCH Venture Partners investment in Series A - SciNeuro
Zoo Capital
Zoo Capital investment in Series A - SciNeuro
Lilly Asia Ventures
Lilly Asia Ventures investment in Series A - SciNeuro
General Atlantic
General Atlantic investment in Series A - SciNeuro
Boyu Capital
Boyu Capital investment in Series A - SciNeuro
TF Capital
TF Capital investment in Series A - SciNeuro
Official Site Inspections
http://www.scineuro.com
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "SciNeuro"
SciNeuro - Deciphering the Enigma of Brain …
Prior to joining SciNeuro, she served in roles of increasing responsibility at GSK R&D China, where she grew the organization from 1 to 500 employees. She brings robust …See details»
About Us - SciNeuro Pharmaceuticals
Prior to joining SciNeuro, she served in roles of increasing responsibility at GSK R&D China, where she grew the organization from 1 to 500 employees. She brings robust …See details»
SciNeuro - Crunchbase Company Profile & Funding
SciNeuro Pharmaceuticals is a clinical-stage biotechnology company focused on developing groundbreaking therapies for neurodegenerative diseases. Since its founding in 2020, …See details»
SciNeuro - Contacts, Employees, Board Members, Advisors & Alumni
SciNeuro is a clinical-stage biotechnology company focused on developing groundbreaking therapies for neurodegenerative diseases. ... Experience the new Crunchbase, powered by AI …See details»
SciNeuro Pharmaceuticals - The Org
SciNeuro Pharmaceuticals is a biopharmaceutical company focused on neuroscience that has an established pipeline of novel therapeutic candidates to treat neurodegenerative and other CNS …See details»
SciNeuro - Funding, Financials, Valuation & Investors - Crunchbase
SciNeuro is a clinical-stage biotechnology company focused on developing groundbreaking therapies for neurodegenerative diseases. New. Resources. ... How much funding has this …See details»
Science - SciNeuro Pharmaceuticals
Prior to joining SciNeuro, she served in roles of increasing responsibility at GSK R&D China, where she grew the organization from 1 to 500 employees. She brings robust …See details»
SciNeuro Pharmaceuticals - Drug pipelines, Patents, Clinical trials ...
SciNeuro is committed to delivering medicines that can make a difference to improve the lives of patients around the world, transforming scientific discoveries into groundbreaking therapies. ...See details»
SciNeuro Pharmaceuticals Company Profile - Office Locations
SciNeuro Pharmaceuticals has 5 employees at their 1 location and $100 m in total funding,. See insights on SciNeuro Pharmaceuticals including office locations, competitors, revenue, …See details»
SciNeuro Pharmaceuticals - VentureRadar
SciNeuro Pharmaceuticals is a clinical-stage biotechnology company focused on developing groundbreaking therapies for neurodegenerative diseases. Since its founding in 2020, …See details»
SciNeuro Pharmaceuticals Launches to Bring Innovative …
Dec 8, 2020 SciNeuro Pharmaceuticals, focused on developing innovative medicines for patients with central nervous system (CNS) diseases, today announced its launch and a $100 million …See details»
SciNeuro Pharmaceuticals Announces a License and Option …
Jun 1, 2022 SciNeuro Pharmaceuticals is an innovation-driven, neuroscience-focused biopharmaceutical company with an established pipeline of novel therapeutic candidates to …See details»
SciNeuro Pharmaceuticals and Mabylon AG to Collaborate on …
Oct 26, 2021 SciNeuro Pharmaceuticals is a leading neuromedicine company focused on elevating the standard of care for patients suffering from neurological diseases. With R&D …See details»
前GSK中国研发负责人利民博士创立赛神医药获1亿美元A轮融资_Sci…
2020年12月8日，上海，专注于为中枢神经系统疾病患者开发创新药物的SciNeuro Pharmaceuticals（赛神医药）今天宣布启动，并完成由礼来亚洲基金和和Arch Venture …See details»
Startup Grabs $100 Million to Focus on China’s Untapped
Dec 8, 2020 SciNeuro will focus on key central nervous system (CNS) diseases and plans a mix of internal R&D and strategic partnerships, to develop its pipeline. Li feels like they are the first …See details»
SciNeuro - Crunchbase
SciNeuro is a clinical-stage biotechnology company focused on developing groundbreaking therapies for neurodegenerative diseases. ... Pricing. Log In. Log In. Experience the new …See details»
SciNeuro Pharmaceuticals Launches to Bring Innovative …
Dec 8, 2020 SHANGHAI--(BUSINESS WIRE)-- SciNeuro Pharmaceuticals (www.scineuro.com), focused on developing innovative medicines for patients with central nervous system (CNS) …See details»
SciNeuro - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Jan 13, 2025 Organization. SciNeuro . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 2. Monthly …See details»
SciNeuro Pharmaceuticals Announces the Appointment of Guojun …
Dec 2, 2022 Dr. Guojun Bu, a world-renowned neuroscientist and former Chair, Department of Neuroscience, Mayo Clinic, joins SciNeuro to lead the company’s research and early …See details»
Research highlights roles of nature and nurture in brain organization
Mar 17, 2025 The findings, published March 17 in Nature Human Behaviour, reveal that while key aspects of brain organization are present from birth, there’s also significant capacity for …See details»